Rxwire
Trials & R&D · first seen yesterday, updated yesterday

Crispr on demand? Mutation-agnostic gene therapy trial nears clinic

Crispr genome editing could in theory be programmed to address any gene mutation, providing cures on demand for life-threatening inherited rare diseases in newborns. The challenge is to develop a platform that can be applied at scale and wi…

Summary from BioWorld Articles.

Coverage 1 article · 1 outlet

  1. BioWorld Articles
    Crispr on demand? Mutation-agnostic gene therapy trial nears clinic